Marcaine 150 mg (Bupivacaine Hydrochloride SOLUTION) 150 MG

Marcaine 150 MG is a solution containing bupivacaine hydrochloride, used for epidural pain relief. This product by Pfizer Canada ULC is designed for specific medical applications.

Strength

150 MG

Pack Size

20ML

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Marcaine 150 MG is primarily used for epidural pain relief. Bupivacaine hydrochloride, the active ingredient, is often utilized in medical procedures to manage pain. This solution is administered epidurally, targeting localized pain management. Patients and healthcare providers often seek Marcaine 150 MG for its effectiveness in pain relief during certain medical interventions.

Side Effects

When administered epidurally, Marcaine 150 MG may cause temporary numbness or tingling in the affected area. Some users might experience mild discomfort or itching at the injection site. These effects are generally short-lived and subside as the medication takes effect. Always consult a healthcare professional for personalized advice.

Precautions & Warnings

Marcaine 150 MG should be handled with care, ensuring proper storage and administration. It is crucial to follow the guidelines provided by healthcare professionals to avoid any potential complications. Patients with known allergies to bupivacaine hydrochloride or similar medications should exercise caution. Always inform your healthcare provider about any existing medical conditions or medications you are taking.

Avoid Interactions

Marcaine 150 MG may interact with certain medications, including other local anesthetics and drugs that affect the central nervous system. Alcohol and other depressants should be avoided to prevent potential adverse effects. Always consult a healthcare professional before combining Marcaine 150 MG with other medications.

Frequently Asked Questions

Marcaine 150 MG is used for epidural pain relief, often in medical procedures.

Marcaine 150 MG is administered epidurally, typically by a healthcare professional.

Common effects may include temporary numbness or tingling in the affected area.

Consult a healthcare professional before combining Marcaine 150 MG with other medications.

Patients with known allergies to bupivacaine hydrochloride or similar medications should exercise caution.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.